February 15, 2019
Passage Bio Raises $115.5 Million to Develop Gene Therapies for CNS Disease
Read More
February 15, 2019
Orchard Looks toward Harvesting Expanded Gene Therapy Pipeline
Read More
February 15, 2019
Rare Leader: Lori Sames, CEO, Hannah’s Hope Fund
Read More
February 13, 2019
Study Questions the Value of Priority Review Vouchers as Incentives
Read More
February 12, 2019
Neurogene Raises $68.5 to Advance Gene Therapies for Rare Neurological Diseases
Read More
February 12, 2019
Combining Proteomics with Genomics Helps Pinpoint a Rare Disease
Read More
February 12, 2019
Rare Disease Groups Launch Newborn Screening Study in Australia
Read More
February 12, 2019
FDA Grants Clementia Rare Pediatric Disease Designation by FOP Drug
Read More
February 8, 2019
Connecting Rare Disease Patients in India and the United States
Read More
February 8, 2019
Solid Biosciences Reports Disappointing Preliminary Results of DMD Gene Therapy Study
Read More
February 8, 2019
First Results of In Vivo Gene Editing Trial of MPS II Treatment Show…
Read More
February 8, 2019
Upcoming Events on the Rare Calendar
Read More
February 7, 2019
FDA Approves Sanofi’s Cablivi for Rare Blood-Clotting Disorder aTTP, the First of a…
Read More
February 7, 2019
Rare Leader: Liz Marfia-Ash, President and Founder, GRIN2B Foundation
Read More
February 5, 2019
Sen. Bernie Sanders Investigates $375,000 Price of LEMS Drug
Read More
February 4, 2019
Alexion and Caelum Enter $550M Collaboration in AL Amyloidosis
Read More
February 4, 2019
UK Grant Supports Diagnosis and Treatment of Rare Diseases
Read More
February 4, 2019
ASCO Names Progress in Treating Rare Cancers Advance of the Year
Read More
February 1, 2019
Regenerative Medicine Moves into the Spotlight
Read More
Load More